Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Echocardiography | 19 | 2024 | 1052 | 3.450 |
Why?
|
| Echocardiography, Three-Dimensional | 6 | 2024 | 53 | 2.610 |
Why?
|
| Heart Defects, Congenital | 9 | 2024 | 1817 | 1.510 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2022 | 360 | 1.010 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2024 | 241 | 0.820 |
Why?
|
| Feasibility Studies | 2 | 2024 | 761 | 0.770 |
Why?
|
| Heart Transplantation | 2 | 2020 | 857 | 0.740 |
Why?
|
| Atrial Function, Left | 1 | 2020 | 26 | 0.690 |
Why?
|
| Pediatrics | 4 | 2021 | 1160 | 0.670 |
Why?
|
| Frailty | 1 | 2020 | 104 | 0.590 |
Why?
|
| Heart Ventricles | 4 | 2022 | 770 | 0.560 |
Why?
|
| Aortic Stenosis, Supravalvular | 1 | 2016 | 19 | 0.540 |
Why?
|
| Sinus of Valsalva | 1 | 2016 | 37 | 0.530 |
Why?
|
| Patient Care Bundles | 1 | 2016 | 23 | 0.530 |
Why?
|
| Stroke Volume | 3 | 2022 | 449 | 0.510 |
Why?
|
| Heart Diseases | 1 | 2020 | 485 | 0.500 |
Why?
|
| Quality Improvement | 2 | 2024 | 639 | 0.500 |
Why?
|
| Image Enhancement | 1 | 2016 | 166 | 0.490 |
Why?
|
| Aortic Rupture | 1 | 2016 | 120 | 0.490 |
Why?
|
| Exercise | 1 | 2020 | 820 | 0.460 |
Why?
|
| Postoperative Care | 1 | 2016 | 295 | 0.460 |
Why?
|
| Aortic Aneurysm | 1 | 2016 | 236 | 0.440 |
Why?
|
| Pulmonary Valve Insufficiency | 2 | 2024 | 41 | 0.410 |
Why?
|
| Reproducibility of Results | 7 | 2024 | 2871 | 0.410 |
Why?
|
| Heart Failure | 2 | 2015 | 2154 | 0.400 |
Why?
|
| Pulmonary Valve | 2 | 2024 | 94 | 0.380 |
Why?
|
| Cardiomyopathies | 1 | 2015 | 479 | 0.350 |
Why?
|
| Child | 14 | 2024 | 24515 | 0.350 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2016 | 1111 | 0.340 |
Why?
|
| Diastole | 3 | 2022 | 167 | 0.340 |
Why?
|
| Heart Valve Prosthesis | 2 | 2024 | 301 | 0.320 |
Why?
|
| Adolescent | 9 | 2024 | 19353 | 0.310 |
Why?
|
| Humans | 29 | 2024 | 124332 | 0.300 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2024 | 438 | 0.290 |
Why?
|
| Child, Preschool | 8 | 2024 | 14076 | 0.290 |
Why?
|
| Levocardia | 1 | 2007 | 3 | 0.290 |
Why?
|
| Case-Control Studies | 3 | 2020 | 3268 | 0.290 |
Why?
|
| Hydrops Fetalis | 1 | 2007 | 75 | 0.280 |
Why?
|
| Atrioventricular Block | 1 | 2007 | 39 | 0.270 |
Why?
|
| Ventricular Function, Left | 4 | 2022 | 495 | 0.270 |
Why?
|
| Systole | 2 | 2015 | 195 | 0.240 |
Why?
|
| Observer Variation | 2 | 2016 | 302 | 0.240 |
Why?
|
| Heart | 3 | 2023 | 718 | 0.220 |
Why?
|
| Prosthesis Design | 2 | 2024 | 683 | 0.220 |
Why?
|
| Prospective Studies | 5 | 2024 | 6084 | 0.220 |
Why?
|
| Cardiac Catheterization | 2 | 2024 | 632 | 0.210 |
Why?
|
| Marfan Syndrome | 1 | 2024 | 139 | 0.200 |
Why?
|
| Recovery of Function | 1 | 2024 | 440 | 0.200 |
Why?
|
| Infant | 7 | 2024 | 12476 | 0.190 |
Why?
|
| Heart Atria | 2 | 2020 | 317 | 0.180 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 2030 | 0.180 |
Why?
|
| Sulfonamides | 1 | 2022 | 261 | 0.180 |
Why?
|
| Male | 10 | 2024 | 60988 | 0.180 |
Why?
|
| Accelerometry | 1 | 2020 | 60 | 0.170 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 241 | 0.170 |
Why?
|
| Diagnostic Errors | 2 | 2024 | 327 | 0.170 |
Why?
|
| Atrial Appendage | 1 | 2020 | 46 | 0.170 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 73 | 0.170 |
Why?
|
| Infant, Newborn | 7 | 2022 | 8184 | 0.160 |
Why?
|
| Female | 11 | 2024 | 66265 | 0.160 |
Why?
|
| Reference Values | 2 | 2022 | 709 | 0.150 |
Why?
|
| Disease Progression | 1 | 2024 | 2038 | 0.150 |
Why?
|
| Missouri | 1 | 2016 | 36 | 0.140 |
Why?
|
| Dilatation, Pathologic | 1 | 2016 | 93 | 0.130 |
Why?
|
| Boston | 1 | 2016 | 110 | 0.130 |
Why?
|
| Vascular Stiffness | 1 | 2016 | 72 | 0.130 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2015 | 79 | 0.120 |
Why?
|
| Regression Analysis | 1 | 2015 | 775 | 0.110 |
Why?
|
| Quality Indicators, Health Care | 1 | 2015 | 216 | 0.110 |
Why?
|
| Graft Rejection | 1 | 2015 | 588 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2015 | 1400 | 0.090 |
Why?
|
| Phenotype | 1 | 2020 | 4255 | 0.090 |
Why?
|
| Quality of Life | 1 | 2020 | 1949 | 0.090 |
Why?
|
| Myocardium | 1 | 2015 | 997 | 0.080 |
Why?
|
| Neoplasms | 1 | 2023 | 2795 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2024 | 12279 | 0.080 |
Why?
|
| Pulmonary Surfactants | 1 | 2007 | 43 | 0.070 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2007 | 38 | 0.070 |
Why?
|
| Epoprostenol | 1 | 2007 | 67 | 0.070 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2007 | 79 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 2896 | 0.070 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2007 | 89 | 0.070 |
Why?
|
| Fatal Outcome | 1 | 2007 | 356 | 0.070 |
Why?
|
| Prognosis | 1 | 2015 | 4554 | 0.060 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 5106 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2015 | 3371 | 0.060 |
Why?
|
| Balloon Valvuloplasty | 1 | 2024 | 25 | 0.060 |
Why?
|
| Mitral Valve Prolapse | 1 | 2024 | 28 | 0.060 |
Why?
|
| Antihypertensive Agents | 1 | 2007 | 397 | 0.060 |
Why?
|
| Syndrome | 1 | 2007 | 1125 | 0.060 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2024 | 22 | 0.060 |
Why?
|
| United States | 3 | 2024 | 10767 | 0.050 |
Why?
|
| Europe | 1 | 2024 | 352 | 0.050 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2024 | 151 | 0.050 |
Why?
|
| Propylene Glycol | 1 | 2002 | 9 | 0.050 |
Why?
|
| Lorazepam | 1 | 2002 | 12 | 0.050 |
Why?
|
| Multimodal Imaging | 1 | 2023 | 111 | 0.050 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2024 | 157 | 0.050 |
Why?
|
| Mitral Valve | 1 | 2024 | 247 | 0.050 |
Why?
|
| Hypnotics and Sedatives | 1 | 2002 | 135 | 0.050 |
Why?
|
| Data Collection | 1 | 2023 | 383 | 0.050 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2007 | 963 | 0.050 |
Why?
|
| Consensus | 1 | 2024 | 629 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2024 | 844 | 0.040 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2020 | 114 | 0.040 |
Why?
|
| Allied Health Personnel | 1 | 2021 | 74 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2022 | 374 | 0.040 |
Why?
|
| Hospital Costs | 1 | 2020 | 178 | 0.040 |
Why?
|
| Hospitals, Pediatric | 1 | 2020 | 782 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2024 | 4730 | 0.030 |
Why?
|
| Length of Stay | 1 | 2020 | 1307 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2024 | 16223 | 0.030 |
Why?
|
| Middle Aged | 2 | 2024 | 26442 | 0.030 |
Why?
|
| Pregnancy | 1 | 2007 | 7166 | 0.030 |
Why?
|
| Time Factors | 1 | 2024 | 6262 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2024 | 3576 | 0.020 |
Why?
|
| Adult | 2 | 2024 | 29378 | 0.020 |
Why?
|
| Young Adult | 1 | 2024 | 8978 | 0.020 |
Why?
|
| Risk Factors | 1 | 2024 | 10139 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 2007 | 64 | 0.020 |
Why?
|
| Intermittent Positive-Pressure Ventilation | 1 | 2007 | 8 | 0.020 |
Why?
|
| High-Frequency Ventilation | 1 | 2007 | 16 | 0.020 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2007 | 50 | 0.020 |
Why?
|
| Foramen Ovale, Patent | 1 | 2007 | 15 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2007 | 180 | 0.020 |
Why?
|
| Echocardiography, Doppler | 1 | 2007 | 171 | 0.020 |
Why?
|
| Hypoxia | 1 | 2007 | 246 | 0.020 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2007 | 145 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2002 | 177 | 0.010 |
Why?
|
| Lactic Acid | 1 | 2002 | 147 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2002 | 548 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2002 | 1018 | 0.010 |
Why?
|